Authorised Therapeutic exploratory (Phase II) Prosthetic Joint Infection

Antibiotic Impregnated Bone Graft to reduce infection in hip replacement - the ABOGRAFT trial

EU CTIS ID: 2024-510921-25-00

What this study is testing

To investigate whether antibiotic impregnated bone graft (AIBG) decreases the risk of infection 2 years after hip arthroplasty, compared to controls treated with placebo impregnated bone graft.

  • Therapeutic exploratory (Phase II)

A plain-language read of the study's public EU CTIS listing. The study team confirms the details.

Who can take part

You may be able to join if

  • Age ≥ 18 years
  • Hip arthroplasty requiring bone graft
  • Willing to provide informed consent
  • For females of childbearing potential; a negative pregnancy test prior to reoperation

You likely can't join if

  • Ongoing prosthetic joint infection
  • Known allergies and contraindications for the use of vancomycin or tobramycin
  • Mental inability, reluctance, or language difficulties that according to investigator judgement, result in difficulty understanding the meaning of study participation
  • Expected difficulties to complete 2-year follow-up
  • Females of child bearing potential not using contraception
  • Pregnant females
See the full eligibility criteria
Who can join
  • Age ≥ 18 years
  • Hip arthroplasty requiring bone graft
  • Willing to provide informed consent
  • For females of childbearing potential; a negative pregnancy test prior to reoperation
What rules you out
  • Ongoing prosthetic joint infection
  • Known allergies and contraindications for the use of vancomycin or tobramycin
  • Mental inability, reluctance, or language difficulties that according to investigator judgement, result in difficulty understanding the meaning of study participation
  • Expected difficulties to complete 2-year follow-up
  • Females of child bearing potential not using contraception
  • Pregnant females
  • Nursing females

The study team makes the final eligibility decision.

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.